GC Biopharma and Hanmi Pharm export Fabry disease drug candidate to US firm for ₩640B
High impactPredicted impact: High
₩640B tech export, about 13% of Hanmi's market value and 39% of revenue.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.